Spatial Biology – Webinars and Online Events

Returning for its third year, this online symposium will once again bring together leading scientists in the field as they highlight the latest advancements in translational proteomics and metabolomics. From uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.

Join us for an invigorating spatial discussion, where we show the latest data using the PhenoCycler™-Fusion system, the fastest single-cell spatial biology solution.

Dr. Nemes will share developments from his lab that enabled the in situ and in vivo measurement of metabolites and proteins in single cells in live tissues and organisms, while Dr. Orsburn will explain how leaps in mass spectrometry can facilitate unprecedented sequence coverage of protein at the single-cell level.

These technologies can help identify new strategies to enhance myocardial repair and regeneration through target validation and manipulation.

Watch this webinar to learn how to import data, identify discriminating variables as well as Visualize the results in different plot types such as PCA, heatmaps, box plots etc.

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

To gain a more comprehensive view of complex disorders of the human brain, researchers need innovative technologies to discover new insights at the molecular, cellular and tissue levels.

Accessed via mobile, tablet or PC, this free-to-attend inaugural online symposium will provide cancer researchers with a unique opportunity to hear about the advances taking place within omics research, immunology, drug discovery and other notable topics.

In this webinar, Dr. Kristin G. Anderson, Research Associate from the Greenberg lab at the Fred Hutchinson Cancer Research Center, discusses engineering T cells to improve survival in the immunosuppressive tumor microenvironment.

Vanderbilt University Medical Center researchers Robert Carnahan and Pavlo Gilchuk are attempting to compress the timeline for therapeutic antibody development, by integrating a series of advances in single-cell messenger RNA sequence analysis, bioinformatics, synthetic biology and high-throughput functional analysis.